The majority of molecular diagnostics systems available on the market today are extremely complex and require considerable hands-on time in addition to highly qualified laboratory personnel. As such, their availability for use is very limited to central laboratories and specialist laboratories.
With the Unyvero solution, Curetis has introduced a brand-new molecular diagnostics system to the market. This new system enables reliable and extremely rapid diagnosis of severe infectious diseases within just four to five hours. The system tests a wide variety of pathogens and antibiotic resistance markers simultaneously.
Curetis’ Subsidiary Ares Genetics Advances AI-powered Infectious Disease and Antibiotic Resistance Test
Curetis’ Subsidiary Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance
Reanimation Congress 2019 - Paris, France - 23 to 25 January, 2019
29. Symposium Intensivmedizin + Intensivpflege - Bremen, Germany - 20 to 22 February, 2019